Researchers unveil six novel rodent hosts of hantavirus and spotlight US epicenters, unraveling how climate and environment intertwine with the virus’s unsettling adaptability.
A study uncovered how the brain archives cold encounters as memory engrams, sparking future metabolic adjustments even without environmental temperature changes.
A wave of respiratory illnesses—including Influenza B, enterovirus-D68 (EV-D68), and human metapneumovirus—is sweeping across the Bay Area.
A newly discovered genetic connection suggests that myotonic dystrophy type 1 (DM1) may increase the likelihood of developing autism spectrum symptoms.
The drug candidate orforglipron from Lilly holds promising potential to become a groundbreaking weight loss and diabetes management remedy requiring additional testing and regulatory clearance.
A breakthrough investigation shows potential to transform liver failure treatment since it offers life-saving possibilities for those on transplant waiting lists.
Pfizer stopped its development of the obesity medication danuglipron due to safety issues as they prioritize their work on novel obesity drug candidates.
Health and economic benefits derived from medically tailored meal programs have the power to revolutionize healthcare services for vulnerable patients spanning across the nation.